The hallmarks of aging · Whole-body effects

Chronic inflammation

Scientific name: Inflammaging

Inflammation is the immune system's response to injury or infection, and it is meant to switch off when the job is done. With age, a low, constant level of inflammation sets in with no infection behind it. Researchers call this inflammaging.

Measurable today: partly, with a common blood test (CRP) that shows inflammation but not its source.

Why it matters

Why it matters to you

It feeds many other aging drivers.

Constant inflammation damages DNA, pushes cells into senescence, and wears down stem cells, and those changes release still more inflammatory signals.

Lowering inflammation alone cut heart events in a large trial.

In 10,061 people with a past heart attack, an antibody that blocks one inflammatory signal lowered repeat heart attacks, strokes, and heart deaths by about 15 percent at one dose, without lowering cholesterol.

Source: PubMed 28845751

Some inflammation is needed.

Short bursts fight infection and drive repair. The problem is the steady, low-level kind that never fully switches off.

Measurement

Can it be measured?

High-sensitivity CRP

Standard blood test

What it showsThe level of a liver protein that rises with inflammation anywhere in the body.

LimitsInfection, injury, extra body fat, and smoking all raise it, and it does not show where the inflammation comes from. One reading is a snapshot.

IL-6 and other inflammatory signals

Doctor-ordered and specialty labs

What it showsLevels of signaling proteins that drive inflammation, such as IL-6.

LimitsThey vary a lot within the same person from day to day, and results from different labs are hard to compare.

Inflammatory aging clock

Research, offered by one company

What it showsA score built from immune proteins in blood, first developed in 1,001 people aged 8 to 96. It tracked frailty, multiple illnesses, and blood vessel aging.

LimitsIt still needs confirming in more groups of people, and two of its developers co-founded the company that offers it.

Sources: PubMed 34888528

What would make it measurable

  • A standard test that separates chronic, aging-related inflammation from short-term illness.
  • Tests that show where in the body the inflammation comes from.
  • Trials showing that lowering inflammation slows aging in healthy people.
What can be done

What can be done about it?

Twenty-four items in our catalog have human studies that support an effect on inflammation, including omega-3, curcumin, exercise, and vitamin D. Many lower a blood marker such as CRP, but a lower marker is not proof of slower aging, and no product has been shown to slow aging in people this way.

Three examples from our catalog, rotated daily: one with stronger evidence here, one with early evidence, and one where we found none. A sample, not a ranking or a recommendation. Ratings as of October 25, 2026. What the evidence levels mean.

Gut & Fiber

Resistant Starch

Evidence for chronic inflammation: Supported

Human studies support it engaging this aging driver, short of the strongest trial designs.

Botanical

Fisetin

Evidence for chronic inflammation: Emerging

Only early or animal-stage evidence for this aging driver so far.

Botanical

Cycloastragenol

Evidence for chronic inflammation: None found

We did not find qualifying evidence that it engages this aging driver.

We have not found strong evidence for it in any aging driver yet.

See the full picture for your own routine

The Longevity Intelligence Report shows how what you take and do covers chronic inflammation and the other hallmarks. Members also see every item in our catalog ranked by the strength of its evidence for chronic inflammation. Opens in December.

Get early access
New research

New studies on chronic inflammation

Picked for what they add to the biology, and to the chance of one day treating it, in plain words. Research checked October 17, 2026.

Chronic inflammation

Immune aging differs widely between people, and one T-cell balance tracked who aged poorly

People, 2,609 healthy adults in several countries, plus four protein cohorts · Immunity · October 9, 2026

What they foundAcross 59 immune cell types, some aging changes appeared everywhere and others differed by sex and ancestry. The balance between two kinds of killer T cells separated healthier from less healthy aging, and a related blood protein signature went with inflammation and higher death risk.

What it does not showAssociations, not cause. Lifelong virus exposure, such as to CMV, shapes the same balance, and some authors have a related patent application.

Why it mattersIt points to measurable immune features that could one day show whether an intervention slows immune aging.

Read the study on PubMed ↗
Single-cell analyses of global cohorts outline determinants of immune aging and link the ratio of GZMK(+) to GZMB(+) Tem cells to health trajectories.
Chronic inflammation

A gut bacterium that fades with age calmed inflammation and kept old mice fitter

People in Chinese cohorts, plus mice · Nature Aging · August 25, 2026

What they foundOne gut bacterium was consistently lower in older people. Given by mouth to old mice, it reduced inflammation in several organs and improved thinking and movement. A compound it makes did much the same.

What it does not showThe benefits were shown in mice. It does not show that a probiotic product helps people age more slowly.

Why it mattersIt ties the gut to inflammaging through a specific microbe and molecule that can now be tested in people.

Read the study on PubMed ↗
A geroprotective probiotic and its functional metabolite counteract inflammaging to extend healthspan.
Chronic inflammation

Turning down an immune sensor, not switching it off, extended life in fast-aging mice

Mice with a premature-aging condition · Nature Communications · August 19, 2026

What they foundA sensor called STING detects DNA that has leaked where it should not be and drives inflammation. A drug that partly blocked it eased bone loss and cell aging and extended lifespan, while removing STING entirely helped little.

What it does not showThese were mice with a rare premature-aging condition, not normal aging.

Why it mattersIt suggests the goal is to calm inflammation, not to shut down the immune response.

Read the study on PubMed ↗
CK2α restriction of STING accumulation underlies systemic aging.

Follow the research on chronic inflammation

Pick the ones you want to follow. Starting in December, we'll email you every two weeks when new studies or new tests come out on them. Longevity Intelligence Report members also get the plain-English read on each one: why it matters, and whether it should change what you're doing.

Free, no account needed. We keep your email and the topics you pick, nothing else. Unsubscribe anytime.

From the articles

Articles on chronic inflammation

Two Big Glasses of Wine a Night Is Officially “Heavy Drinking”

One or two glasses of red wine with dinner. Not a night out. The next morning my overnight heart rate was up as much as 20 percent, and my heart rate variability was cut by as much as half.

Read the article →

I Went Into Research to Study Aging. Then I Needed a Stent at 44.

What aging biology can tell us about the supplements, tests and habits we pay for: the 12 hallmarks of aging, plus a candidate 13th, in plain English.

Read the article →

What Keeps Plaque in Your Heart Arteries From Rupturing?

Is soft plaque dangerous? Whether a plaque ruptures depends on its fibrous cap, which no CT report measures. What thins it, and the trials where caps thickened.

Read the article →

Your Angiogram Was Clean. Nobody Tested Whether Your Artery Clamps.

Coronary artery spasm is diagnosed with an acetylcholine test in the cath lab, not an angiogram. What it measures, why it is rarely run, how drugs blunt it.

Read the article →

I Was Ready to Pay to Watch My Plaque Shrink. Then I Learned the Number Moves on Its Own.

AI plaque analysis from Cleerly and HeartFlow measures arteries to the cubic millimeter. Rescan an hour later and the number moves. Read before you pay for one.

Read the article →

Aging's Zombie Cells Have an Inflammatory Fuel Line. Mayo Just Found the Valve.

Why zombie cells fuel inflammaging: a Mayo-led Nature study traces the mitochondrial fuel line that keeps inflammation genes open, and the valve that shuts it.

Read the article →

I Crushed My ApoB to 38. Nobody Measured My Small Vessels.

Coronary microvascular dysfunction hides behind a clean angiogram. How it is diagnosed, why inflammation drives it, and why an ApoB of 38 was not enough.

Read the article →

The Heart-Attack Risk Hiding in Your Immune Cells

Clonal hematopoiesis (CHIP): a blood mutation that roughly doubles coronary risk. No cardiology society screens for it. Why, and why I stopped chasing the test.

Read the article →

The Heart Attacks You Never Feel

What happens when coronary plaque ruptures and heals instead of killing you: a silent wound that narrows the artery. It likely built my 80% blockage at 44.

Read the article →

Blood Pressure Isn’t a Moment. It’s a Dose Your Arteries Absorb for Decades.

132/85 is now Stage 1 hypertension, and a single reading is one sample of a dose your arteries absorb every beat, for decades. Mine sat there for twenty years.

Read the article →

What Twenty Years of “Borderline” LDL Actually Costs You

An LDL of 145 at 35 isn’t a snapshot. It’s 2,175 mg-years of exposure your arteries have already logged, and “borderline” is the word that hides the bill.

Read the article →
Go deeper

Connected hallmarks

How the biology works

Inflammaging is chronic, low-grade, and sterile, and that word sterile is the whole point. Normal inflammation is acute and aimed: an infection or injury triggers a sharp immune response that clears the threat and then resolves, switching cleanly back off. Inflammaging is different on every count. It is low-grade (a faint hum rather than a roaring fire), chronic (it never fully resolves), and sterile (it runs without any germ to fight). The immune system is reacting not to invaders but to the accumulating wreckage of aging itself, and because that wreckage is always present, the off switch never gets pulled.

The triggers are danger signals released by the body's own damaged parts. When cells are stressed or dying they spill molecules the immune system was built to treat as alarms, known collectively as damage-associated molecular patterns. These include fragments of DNA in the wrong place, leaked mitochondrial contents, and bits of broken-down tissue. Pattern-recognition receptors, the immune system's smoke detectors (including the TLR family on cell surfaces), read these self-derived alarms the same way they would read a bacterium, so a body that is quietly accumulating damage is a body that is quietly setting off its own alarms.

NF-kB is the master inflammatory switch all of this converges on. NF-kB (nuclear factor kappa B) is a control protein that sits in the cell waiting, and when a danger signal arrives it moves into the cell's command center and switches on the genes for dozens of inflammatory messengers at once. It is the central relay where the many separate triggers of inflammaging funnel into a single coordinated output, which is why nearly every thread in this hallmark passes through it. With age NF-kB activity drifts upward and stays elevated, locking in the low-grade hum.

The NLRP3 inflammasome is a second key amplifier, a built-in alarm-and-blade assembly. An inflammasome is a cluster of proteins that snaps together inside a cell when it senses danger; the NLRP3 version is the one most tied to aging. Once assembled it activates a molecular blade (an enzyme called caspase-1) that cuts two especially potent inflammatory messengers, IL-1-beta and IL-18, into their active form and releases them. Crystallized cholesterol, misfolded proteins, and excess uric acid can all trip NLRP3, which is one mechanistic reason metabolic excess and aging stoke inflammation so reliably.

The core inflammatory messengers are IL-6, IL-1-beta, and TNF-alpha. These are cytokines, the small signaling proteins immune cells use to talk to one another and to the rest of the body. IL-6 (interleukin-6) drives the liver to make C-reactive protein and is the messenger most tightly tied to frailty and mortality in aging. IL-1-beta is the product of the inflammasome above and a powerful initiator that recruits more inflammation. TNF-alpha (tumor necrosis factor alpha) is strongly catabolic, meaning it pushes the body to break tissue down, which is part of why chronic inflammation erodes muscle. Together these three are the chemical signature of inflammaging.

Senescent cells feed the fire through their SASP, the bridge to senescent cells. Senescent cells are damaged cells that stop dividing but refuse to die, and they broadcast a cocktail of inflammatory and tissue-degrading signals called the SASP (the senescence-associated secretory phenotype). The SASP is essentially a localized inflammaging generator: it is rich in exactly the IL-6, IL-1, and tissue-remodeling factors above, it pushes nearby healthy cells toward senescence too, and as senescent cells accumulate with age their collective broadcast becomes a major source of the body-wide inflammatory hum.

Gut-barrier leakage adds microbial fuel, the bridge to gut microbe imbalance. The gut lining is a one-cell-thick wall separating trillions of microbes from the bloodstream, and with age (and with the microbiome shifts of dysbiosis) that wall grows leakier. Microbial products, especially a molecule called LPS (lipopolysaccharide, a fragment of the outer coat of certain gut bacteria), seep across into circulation, where the immune receptor TLR4 reads LPS as a powerful danger signal and switches on NF-kB. This gut-to-blood-to-inflammation route, sometimes called metabolic endotoxemia, is a constant low-level provocation that rises as the barrier weakens.

Immunosenescence means the immune system itself ages and miscalibrates. With age the immune system undergoes a double shift: the part that mounts precise, targeted responses weakens (fewer fresh, naive immune cells, partly because the thymus shrinks), while the older, blunter inflammatory arm grows more trigger-happy. The result is an immune system that is simultaneously worse at clearing real threats and quicker to fire off nonspecific inflammation, which both raises the background hum and leaves more unresolved damage for that hum to react to.

All of these close into a self-amplifying loop, which is the core danger. Inflammation damages tissue, worsens insulin resistance, and accelerates DNA damage and senescence; the new senescent cells and damaged mitochondria then release more danger signals; those signals drive more inflammation. Each turn of the loop deepens the next, which is why inflammaging tends to compound rather than plateau, and why it acts as an accelerant across the whole hallmark network rather than as one isolated problem.

Where treatment research is heading
Next few years

Proven anti-inflammatory levers: exercise, diet, sleep, and omega-3

The most reliable ways to lower the inflammatory hum are also the lowest-risk: regular exercise, a whole-food dietary pattern, adequate sleep, losing excess visceral fat, and omega-3 fatty acids all measurably reduce hs-CRP and IL-6, and several carry independent cardiovascular and metabolic outcome data. Because these markers are cheap to track and respond to behavior, they give a genuine feedback loop for habits that help regardless of the inflammation question.

Not ready yet: A lower marker does not by itself prove slower aging, the effects of any single lever are modest and tangled with other healthy behaviors, and chasing the number alone can mislead since a normal systemic reading can miss tissue-level inflammation.

Repurposed IL-1 and IL-6 biologics, and the CANTOS signal

Drugs that precisely block a single inflammatory messenger, developed for autoimmune disease, are being tested against the diseases of aging. The landmark CANTOS trial used canakinumab, an antibody that neutralizes IL-1-beta, and reduced cardiovascular events independent of cholesterol, the first hard proof that targeting inflammation directly can lower age-related disease, and the same trial saw a striking drop in lung-cancer incidence that is now being followed up.

Not ready yet: These biologics raise the risk of serious infection (CANTOS saw more fatal infections), they are expensive injectables, and a benefit in a specific high-risk disease population is not evidence they should be used as general-purpose longevity tools in healthy people.

Further out

Targeted NLRP3 inflammasome inhibitors

Rather than blunting all inflammation, a new class of drugs aims to block the specific NLRP3 inflammasome that drives much of the sterile, aging-related inflammation behind the IL-1-beta signal. Selectively quieting this one alarm could, in principle, lower inflammaging across multiple tissues while leaving the rest of normal immune defense intact.

Not ready yet: These inhibitors are still in early human trials, the long-term safety of chronically dampening a core innate-immune sensor is unknown, and proof that they slow aging rather than treat a specific inflammatory disease does not yet exist.

Senolytics that remove the SASP source

Because senescent cells are a major engine of inflammaging through their SASP, drugs that selectively clear them (senolytics such as the dasatinib-plus-quercetin combination and the flavonoid fisetin) could shut off a renewable source of inflammatory signaling at the root rather than mopping up the messengers downstream.

Not ready yet: Senolytic human data are early and short, the right targets and doses are unsettled, and clearing the wrong cells could impair wound healing, so a durable anti-inflammatory and healthspan benefit in people is unproven.

Precision immune modulation and pro-resolving mediators

Beyond simply blocking inflammation, researchers are pursuing ways to actively switch it off, including specialized pro-resolving mediators (molecules the body normally makes to end an inflammatory episode cleanly) and more precise immune-tuning approaches that aim to quiet the harmful inflammatory arm without disabling protective defense.

Not ready yet: Resolution biology is young, getting these short-lived molecules to the right place at a useful dose is unsolved, and safe, durable human therapies that retune rather than suppress immunity do not yet exist.

Long shots

Whole-system immune re-calibration and reversing immunosenescence

The far-horizon vision is to reset the aging immune system itself, restoring the precise, targeted responses that fade while calming the trigger-happy inflammatory arm that grows with age, in effect curing inflammaging at its source by rejuvenating the immune system that generates it. Regenerating the shrunken thymus and rebalancing the immune-cell pool are early pieces of this idea.

Not ready yet: Immune aging is woven from many tangled processes at once, we do not know the youthful target state precisely enough to engineer toward it, and broadly re-engineering immunity carries serious risks of autoimmunity or lost defense, so this remains a distant, high-risk goal.

Facts and sources on this page checked October 17, 2026. This page explains research. It is not medical advice or a recommendation to take anything. How we grade the evidence.